Several million Americans signed up for HSAs this year as they grapple with increasingly expensive medical care and health-insurance premiums

WASHINGTON — Comments from a top Trump administration health official add to signs of a major flaw in the president’s most-favored nation drug pricing plans.

Even if the Straight of Hormuz opened tomorrow, economic policy expert Henrietta Treyz says it'll take "at least 200 days" to clear the shipping backlog.

With portfolios steady for now, volatility may offer opportunities, while inflation and politics remain key forces shaping what comes next.

Tariffs are likely here to stay, income tax cuts will require congressional action, and surging AI-driven power demand could become a defining force in markets.

President Donald Trump faced rare pushback in Congress this week over his sweeping tariff policy, as slipping approval ratings and fractures within his party emboldened critics.

The selloff highlights the growing risks insurers face as Washington tightens its grip on Medicare Advantage payments.

CMS’s proposal to limit chart reviews could rein in billions in Medicare Advantage overpayments, despite sharp industry backlash.

Analysts questioned whether Trump’s “Great Healthcare Plan” can deliver real relief, citing limited legislative pathways and modest potential impact.